HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by GF Fund Management CO. LTD.

GF Fund Management CO. LTD. lifted its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 35.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,299 shares of the company's stock after acquiring an additional 1,650 shares during the quarter. GF Fund Management CO. LTD.'s holdings in HCA Healthcare were worth $2,177,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the stock. Atwood & Palmer Inc. bought a new stake in shares of HCA Healthcare in the first quarter worth $28,000. Bartlett & CO. Wealth Management LLC grew its stake in shares of HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after purchasing an additional 80 shares during the period. Tidemark LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at about $36,000. ORG Partners LLC grew its position in HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after buying an additional 86 shares during the period. Finally, Legacy Investment Solutions LLC grew its position in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after buying an additional 95 shares during the period. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

HCA Healthcare stock traded up $1.93 during midday trading on Monday, reaching $378.51. 1,369,708 shares of the stock traded hands, compared to its average volume of 1,463,071. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. The stock has a market cap of $91.06 billion, a P/E ratio of 16.83, a PEG ratio of 1.30 and a beta of 1.47. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The stock's fifty day moving average is $372.47 and its 200-day moving average is $340.19.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The business had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same quarter last year, the business earned $5.36 earnings per share. HCA Healthcare's quarterly revenue was up 5.7% compared to the same quarter last year. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were issued a $0.72 dividend. The ex-dividend date was Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Barclays set a $416.00 price objective on shares of HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Morgan Stanley set a $410.00 price objective on HCA Healthcare and gave the company an "equal weight" rating in a research note on Monday, June 9th. Royal Bank Of Canada reiterated an "outperform" rating and set a $404.00 price objective (up from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Guggenheim started coverage on shares of HCA Healthcare in a research report on Wednesday, April 9th. They issued a "neutral" rating for the company. Finally, Robert W. Baird reaffirmed a "neutral" rating and issued a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Seven research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $395.71.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.30% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.